What is the recommended initial management of suspected diabetic ketoacidosis in a child or adolescent?

Initial Management of Pediatric Diabetic Ketoacidosis

Begin immediate fluid resuscitation with 0.9% normal saline at 10-20 mL/kg over the first hour, followed by continuous IV insulin infusion at 0.05-0.1 U/kg/hour starting 1-2 hours after fluids are initiated, and do NOT give an initial insulin bolus in children. 1

Diagnostic Confirmation

Obtain STAT laboratory studies to confirm DKA and guide management: 1

• Venous blood gas (pH <7.3 confirms DKA)
• Serum glucose (>250 mg/dL)
• Electrolytes, BUN, creatinine (check every 2-4 hours during treatment)
• β-hydroxybutyrate (direct measurement preferred over nitroprusside test) 1
• Complete blood count with differential
• Urinalysis
• Calcium and phosphorus

Calculate corrected sodium by adding 1.6 mEq/L for each 100 mg/dL increase in glucose above 100 mg/dL to assess true sodium status. 1

Calculate effective osmolality as 2 × [Na (mEq/L)] + [glucose (mg/dL)] ÷ 18 to guide fluid therapy. 1

Fluid Management Algorithm

Phase 1: Initial Resuscitation (Hour 0-1)

• Administer 0.9% normal saline at 10-20 mL/kg over the first hour (for a 30-kg child, this is 300-600 mL) 1
• Do NOT exceed 50 mL/kg total in the first 4 hours to minimize cerebral edema risk 1

Phase 2: Ongoing Rehydration (Hours 1-24)

If corrected sodium is normal or elevated:

• Switch to 0.45% NaCl at 4-14 mL/kg/hour (120-420 mL/h for a 30-kg child) 1

If corrected sodium is low:

• Continue 0.9% NaCl at the same rate 1

Alternative smooth-rehydration approach:

• Provide 1.5 × maintenance fluids (approximately 5 mL/kg/hour for a 30-kg child) 1

Critical monitoring parameter: Serum osmolality should change ≤3 mOsm/kg per hour to prevent cerebral edema. 1

Insulin Therapy Protocol

DO NOT administer an initial IV insulin bolus in pediatric patients—this is a critical difference from adult protocols. 1

Initiate continuous IV regular insulin infusion:

• Start 1-2 hours AFTER fluid resuscitation begins 1
• Dose: 0.05-0.1 U/kg/hour (1.5-3 U/h for a 30-kg child) 1

If glucose fails to drop ≥50 mg/dL in the first hour:

• Confirm adequate hydration status first 1
• Double the insulin rate hourly until steady glucose decline is achieved 1

Continue insulin infusion until ketoacidosis resolves:

• pH >7.3 1
• Bicarbonate ≥15-18 mEq/L 1
• Anion gap normalized 1
• Do NOT stop insulin when glucose normalizes alone 1

Potassium Replacement

Wait to add potassium until urine output is confirmed at ≥0.5 mL/kg/hour (≥15 mL/h for a 30-kg child). 1

Once adequate urine output is established:

• Add 20-30 mEq/L potassium to IV fluids 1
• Use a mixture of 2/3 potassium chloride and 1/3 potassium phosphate 1

Transition to Dextrose-Containing Fluids

When plasma glucose falls to approximately 250 mg/dL:

• Switch to 5% dextrose in 0.45% NaCl (adjust NaCl concentration to 0.45-0.75% based on sodium status) 1
• Maintain potassium supplementation at 20-30 mEq/L (2/3 KCl + 1/3 KPO₄) 1
• Continue insulin infusion at 0.1 U/kg/hour 1
• Adjust dextrose concentration to maintain glucose 150-200 mg/dL 1

Intensive Monitoring Requirements

Hourly monitoring: 1

• Blood glucose (capillary or venous)
• Neurological status (mental status, headache, behavioral changes)

Every 2-4 hours: 1

• Serum electrolytes (Na, K, Cl)
• Venous pH and bicarbonate
• BUN and creatinine
• Effective osmolality

Continuous cardiac monitoring is essential given rapid potassium shifts during treatment. 1

Severe DKA (pH <7.0, Bicarbonate <10 mEq/L)

Requires ICU admission with: 1

• Central venous pressure monitoring
• Intra-arterial pressure monitoring
• More frequent laboratory assessments
• Higher risk of cerebral edema and mortality 1

Cerebral Edema Recognition and Management

Cerebral edema is the most common life-threatening complication of pediatric DKA and occurs more frequently in children than adults. 1

Early warning signs requiring immediate intervention: 1

• Headache
• Confusion
• Behavioral changes
• Declining mental status

Treatment: Administer mannitol immediately if cerebral edema is suspected. 1, 2

Transition to Subcutaneous Insulin

After ketoacidosis resolves (pH >7.3, bicarbonate ≥15-18 mEq/L): 1

• Initiate subcutaneous insulin 2-4 hours before discontinuing IV insulin 1
• Continue IV insulin for 1-2 hours after starting subcutaneous insulin to prevent rebound ketoacidosis 1

Type-Specific Post-DKA Management

For suspected Type 2 diabetes (overweight/obese presentation):

• Start metformin after acidosis resolves while continuing subcutaneous insulin 3
• Discharge on basal insulin at 0.5 units/kg/day 3
• Titrate metformin from 500 mg daily up to 2000 mg daily in divided doses over 1-2 weeks 3
• Wean insulin by 10-30% every few days if glucose targets are met 2-6 weeks post-discharge 3

For Type 1 diabetes or positive pancreatic autoantibodies:

• Continue or initiate multiple daily injection insulin or pump therapy 4
• Discontinue metformin 4

Prevention of Recurrent DKA

Provide 24-hour telephone support for families of children with diabetes. 1

Educate caregivers on: 1

• Early warning signs of DKA
• Importance of ketone monitoring during intercurrent illness
• Recurrent DKA is almost always due to insulin omission 1

Offer psychological support, as recurrent DKA is associated with psychiatric illness, depression, and eating disorders. 1